Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positive Nodes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06977698
What this trial is testing

Intra-operative Detection of Positive Margins and Lymph Nodes in Breast Surgery

Who this might be right for
Breast Cancer Invasive
University of Nottingham 120
Large-scale testing (Phase 3)Looking for participantsNCT06341621
What this trial is testing

Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib

Who this might be right for
Breast Cancer
Fudan University 1,900
Testing effectiveness (Phase 2)Study completedNCT02427841
What this trial is testing

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic Carcinoma
OHSU Knight Cancer Institute 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT06996093
What this trial is testing

Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor

Who this might be right for
Breast Cancer
Fudan University 2,508
Not applicableEnded earlyNCT03137693
What this trial is testing

Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT04863079
What this trial is testing

Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )

Who this might be right for
ESCCAdjuvant TreatmentLymph Node Positive+1 more
Tianjin Medical University Cancer Institute and Hospital 82
Not applicableNot Yet RecruitingNCT07724769
What this trial is testing

De-escalation of RNI in Breast Cancer Patients With pN0 After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Aya Ahmed Sayed 100
Testing effectiveness (Phase 2)Ended earlyNCT04016142
What this trial is testing

Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer

Who this might be right for
Locally Advanced CancerCervical Cancer
Centre Oscar Lambret 21
Not applicableStudy completedNCT00003566
What this trial is testing

Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 75
Not applicableStudy completedNCT01304667
What this trial is testing

Chemo- and Radiotherapy in Epithelial Vulvar Cancer

Who this might be right for
Radio/Chemotherapy in Node Positive Advanced Vulvar Cancer
AGO Study Group 1,618
Not applicableLooking for participantsNCT06559371
What this trial is testing

68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer

Who this might be right for
BREAST CANCERPET/CT
Kunwei Shen 150
Early research (Phase 1)Looking for participantsNCT05996107
What this trial is testing

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 30
Not applicableStudy completedNCT00544167
What this trial is testing

Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 45
Not applicableActive Not RecruitingNCT02240472
What this trial is testing

Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.

Who this might be right for
Breast Cancer
Karolinska Institutet 2,766
Testing effectiveness (Phase 2)Study completedNCT00446030
What this trial is testing

Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Sanofi 127
Not applicableUnknownNCT01836822
What this trial is testing

Bronchoscopic Sampling Techniques in Sarcoidosis

Who this might be right for
Mediastinal Lymph Node EnlargementSarcoidosisTuberculosis+1 more
Medical University of Warsaw 90
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018
Post-approval studies (Phase 4)Study completedNCT02549677
What this trial is testing

Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer

Who this might be right for
Breast Neoplasms
Ruijin Hospital 294
Not applicableStudy completedNCT00756132
What this trial is testing

Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca

Who this might be right for
Locally Advanced Breast CancerBreast Cancer
University Health Network, Toronto 120
Early research (Phase 1)Ended earlyNCT02205398
What this trial is testing

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Who this might be right for
Squamous Cell Carcinoma of Head and Neck (SCCHN)Metastatic Colorectal Cancer
Novartis Pharmaceuticals 13
Next Page